DENTSPLY SIRONA INCXRAY
ASignal's systematic analysis rates XRAY as Neutral.
Reflects the latest available analysis · analyzed Sep 9, 2026
The case on XRAY
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Free cash flow positive at $141.62M
- Gross margin of 49.52% indicates strong pricing power
- Low forward P/E of 7.01x relative to sector
- PEG ratio of 0.74x suggests undervaluation relative to growth potential
- EV/EBITDA of 8.13x below typical growth threshold
- Negative net margin of -14.99%
- Negative return on equity (-33.03%)
- Declining revenue with YoY growth of -4.10%
- High debt-to-equity ratio of 1.72x
- Quick ratio of 0.72x indicates liquidity concerns
- MACD below signal line with negative momentum
See the full verdict on XRAY
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes XRAY
Most investors never get a second opinion, let alone several. ASignal runs XRAY past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.